glp-1 drugs companies Market Overview: Agonists and the Obesity Market | Blog Selling Faster Than Hotcakes: GLP-1

A state-by-state look at how affordable GLP-1 drugs like Ozempic and Zepbound really are and where cost keeps patients from access.

hazard ratio 1.60, 95% CI 1.37 to 1.87) but not after confounding factors were accounted for (0.91, 0.73 to 1.12)

Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF

Over the last year, the Indian obesity-treatment market has changed very fast

A closer look at how GLP-1 medications may impact fertility, PCOS, and reproductive health.

The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply. | The demand for weight loss drugs is not slowing down, and many organizations voiced concerns there will likely be semaglutide shortages in the future that will impact patients' access to weight loss medications.